Deltagen Gains At Least $10M In Private Financing Commitment April 7, 2003 By Aaron Lorenzo No Comments
Deltagen Gains At Least $10M In Private Financing Commitment April 7, 2003 By Aaron Lorenzo No Comments
Orchid Brings In $16M Through Private Sale Of Preferred Stock April 3, 2003 By Aaron Lorenzo No Comments
Orchid Brings In $16M Through Private Sale Of Preferred Stock April 3, 2003 By Aaron Lorenzo No Comments
Viragen Secures $12M In Credit To Essentially Fund Operations April 2, 2003 By Aaron Lorenzo No Comments
Viragen Secures $12M In Credit To Essentially Fund Operations April 2, 2003 By Aaron Lorenzo No Comments
Synta Steps Out Of The Shadows With $75.3M Funding For Pipeline March 31, 2003 By Aaron Lorenzo No Comments On its website, Synta Pharmaceuticals Inc. bills itself as the newest 10-year-old pharma firm in Boston. (BioWorld Today)Read More
Synta Steps Out Of The Shadows With $75.3M Funding For Pipeline March 31, 2003 By Aaron Lorenzo No Comments On its website, Synta Pharmaceuticals Inc. bills itself as the newest 10-year-old pharma firm in Boston. (BioWorld Today)Read More
Telik Begins Registration Study Of TLK286 In Ovarian Cancer March 28, 2003 By Aaron Lorenzo No Comments Plans to push its lead compound into a Phase III trial has Telik Inc. beaming like a proud parent at a child's graduation. (BioWorld Today)Read More
Telik Begins Registration Study Of TLK286 In Ovarian Cancer March 28, 2003 By Aaron Lorenzo No Comments Plans to push its lead compound into a Phase III trial has Telik Inc. beaming like a proud parent at a child's graduation. (BioWorld Today)Read More
